Skip to main content

Table 3 Summary of statistical analysis of fed/fasted comparison (Study 2)

From: The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects

  Danirixin 100 mg Fed Danirixin 100 mg Fasted Treatment Difference(Fed vs. Fasted)
  n Adjusted Geometric Mean(SE Logs) n Adjusted Geometric Mean(SE Logs) Estimate 90 % CI
AUC (0-∞)(ng h/mL) 15 12,635 (0.082) 13 15,047 (0.088) 0.840 (0.684, 1.031)
Cmax(ng/mL) 16 1411 (0.076) 15 2239 (0.078) 0.630 (0.523, 0.758)